FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2952578224> ?p ?o ?g. }

• W2952578224 abstract "Background: TAFRO syndrome is a clinical subtype of idiopathic multicentric Castleman disease (iMCD) that is characterized by thrombocytopenia, anasarca, fever and/or elevated serum C-reactive protein, renal dysfunction, and organomegaly. Case presentation: A 28-year-old woman with fever, weight gain of 13kgs, lower extremity edema, hepatosplenomegaly, and multicentric peripheral lymphadenopathy was referred to our center. Laboratory investigations revealed anemia, thrombocytopenia, creatinine at 1.19 mg/dL and hypoalbuminemia at 33 g/L. Proteinuria was measured at 2 g/day including albuminuria at 1.5 g/day. Urinary sediment examination found leukocyturia at 44,000/mL and hematuria at 645,000/mL. Vascular endothelial growth factor (VEGF) level was elevated. A cervical lymph node biopsy found features consistent with the mixed histopathological subtype of iMCD. A renal biopsy revealed a membranoproliferative glomerulonephritis (MPGN) pattern. We initiated 3 days of methylprednisolone pulse-therapy at 1000mg per day, followed by prednisone 1mg/kg/day and evolution was favorable. Review of literature: 19 iMCD patients with TAFRO syndrome had undergone a renal biopsy: 8 cases with author’s diagnosis consistent with MPGN-like and 11 cases of thrombotic microangiopathy (TMA)-like glomerulopathy without fibrin thrombi in glomerular capillaries or arterioles and without typical biological signs. Clinical, biological, and outcome characteristics were similar between the cases described as having MPGN and TMA-like presentation. After a thorough review of histopathological descriptions for each case, MPGN lesions seems to be the consequences of chronic glomerular endothelial injury in persistent TMA. We suspect that VEGF and IL-6 play a key role in the physiopathology of the spectrum of renal involvement from TMA-like to MPGN observed in TAFRO syndrome. Conclusion: We present a Caucasian iMCD patient with TAFRO syndrome with renal insufficiency secondary to MPGN, which might be secondary to a chronic TMA-like disease. We suspect that there is a continuum between TMA and MPGN lesions in TAFRO syndrome favored by VEGF and IL-6." @default.
• W2952578224 created "2019-06-27" @default.
• W2952578224 creator A5014020914 @default.
• W2952578224 creator A5015042510 @default.
• W2952578224 creator A5018085838 @default.
• W2952578224 creator A5018486655 @default.
• W2952578224 creator A5027654738 @default.
• W2952578224 creator A5027696823 @default.
• W2952578224 creator A5029932924 @default.
• W2952578224 creator A5051699635 @default.
• W2952578224 creator A5055188307 @default.
• W2952578224 creator A5069345610 @default.
• W2952578224 creator A5085185299 @default.
• W2952578224 date "2019-06-28" @default.
• W2952578224 modified "2023-10-14" @default.
• W2952578224 title "Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review" @default.
• W2952578224 cites W1494879962 @default.
• W2952578224 cites W1759339444 @default.
• W2952578224 cites W1992591810 @default.
• W2952578224 cites W2028031291 @default.
• W2952578224 cites W2040057687 @default.
• W2952578224 cites W2060912271 @default.
• W2952578224 cites W2061649065 @default.
• W2952578224 cites W2074936672 @default.
• W2952578224 cites W2084023166 @default.
• W2952578224 cites W2087734464 @default.
• W2952578224 cites W2098600061 @default.
• W2952578224 cites W2100894499 @default.
• W2952578224 cites W2110001721 @default.
• W2952578224 cites W2126846432 @default.
• W2952578224 cites W2138240066 @default.
• W2952578224 cites W2138707791 @default.
• W2952578224 cites W2145291136 @default.
• W2952578224 cites W2150642904 @default.
• W2952578224 cites W2150893441 @default.
• W2952578224 cites W2335216819 @default.
• W2952578224 cites W2413375808 @default.
• W2952578224 cites W2518690004 @default.
• W2952578224 cites W2553923194 @default.
• W2952578224 cites W2554898960 @default.
• W2952578224 cites W2572250031 @default.
• W2952578224 cites W2600663319 @default.
• W2952578224 cites W2756783609 @default.
• W2952578224 cites W2761854747 @default.
• W2952578224 cites W2781097454 @default.
• W2952578224 cites W2792837699 @default.
• W2952578224 cites W2796058658 @default.
• W2952578224 cites W2804627687 @default.
• W2952578224 cites W2806647481 @default.
• W2952578224 cites W2808428445 @default.
• W2952578224 cites W2809569713 @default.
• W2952578224 cites W2883944750 @default.
• W2952578224 cites W2893800912 @default.
• W2952578224 cites W2906124486 @default.
• W2952578224 doi "https://doi.org/10.3389/fimmu.2019.01489" @default.
• W2952578224 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6609882" @default.
• W2952578224 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31316523" @default.
• W2952578224 hasPublicationYear "2019" @default.
• W2952578224 type Work @default.
• W2952578224 sameAs 2952578224 @default.
• W2952578224 citedByCount "20" @default.
• W2952578224 countsByYear W29525782242020 @default.
• W2952578224 countsByYear W29525782242021 @default.
• W2952578224 countsByYear W29525782242022 @default.
• W2952578224 countsByYear W29525782242023 @default.
• W2952578224 crossrefType "journal-article" @default.
• W2952578224 hasAuthorship W2952578224A5014020914 @default.
• W2952578224 hasAuthorship W2952578224A5015042510 @default.
• W2952578224 hasAuthorship W2952578224A5018085838 @default.
• W2952578224 hasAuthorship W2952578224A5018486655 @default.
• W2952578224 hasAuthorship W2952578224A5027654738 @default.
• W2952578224 hasAuthorship W2952578224A5027696823 @default.
• W2952578224 hasAuthorship W2952578224A5029932924 @default.
• W2952578224 hasAuthorship W2952578224A5051699635 @default.
• W2952578224 hasAuthorship W2952578224A5055188307 @default.
• W2952578224 hasAuthorship W2952578224A5069345610 @default.
• W2952578224 hasAuthorship W2952578224A5085185299 @default.
• W2952578224 hasBestOaLocation W29525782241 @default.
• W2952578224 hasConcept C126322002 @default.
• W2952578224 hasConcept C142724271 @default.
• W2952578224 hasConcept C2775892965 @default.
• W2952578224 hasConcept C2775934546 @default.
• W2952578224 hasConcept C2776009029 @default.
• W2952578224 hasConcept C2776054410 @default.
• W2952578224 hasConcept C2776548574 @default.
• W2952578224 hasConcept C2777878052 @default.
• W2952578224 hasConcept C2778415529 @default.
• W2952578224 hasConcept C2778551932 @default.
• W2952578224 hasConcept C2778930706 @default.
• W2952578224 hasConcept C2779134260 @default.
• W2952578224 hasConcept C2779440204 @default.
• W2952578224 hasConcept C2779561371 @default.
• W2952578224 hasConcept C2780091579 @default.
• W2952578224 hasConcept C2781036514 @default.
• W2952578224 hasConcept C2781087799 @default.
• W2952578224 hasConcept C71924100 @default.
• W2952578224 hasConcept C90924648 @default.
• W2952578224 hasConceptScore W2952578224C126322002 @default.
• W2952578224 hasConceptScore W2952578224C142724271 @default.
• W2952578224 hasConceptScore W2952578224C2775892965 @default.

• next